Sun Pharma in collaboration with Weizmann Institute of Science, Israel & Health Research…
Adopts novel approach towards development of a treatment for glioblastoma, a lethal form of brain cancer
Sun Pharmaceutical…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Sun Pharmaceutical Industries » Page 2
Browsing Tag
Sun Pharmaceutical Industries
Sun Pharma receives US FDA approval for Gleevec
These tablets are indicated for the treatment of chronic myeloid leukemia
Sun Pharma acquires InSite Vision
The acquisition was completed by means of a short-form merger under Delaware law
Sun Pharmaceutical Industries has acquired…
Sun Pharma announces Absorica patent litigation settlement
Ranbaxy Pharmaceuticals along with its partners, Cipher Pharmaceuticals and Galephar Pharmaceutical Research have entered into a…
Sun Pharma commences tender offer for acquisition of InSite Vision
The tender offer will expire on October 27, 2015, at 12:00 midnight New York City time
Sun Pharmaceutical Industries has…
Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy
The agreement involves transfer of Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides for a consideration…
Sun Pharma to acquire InSite Vision
Strengthens branded ophthalmic portfolio in US
Sun Pharmaceutical Industries' subsidiary has entered into an agreement and plan…
Sun Pharma, Wockhardt recall drugs from US market
Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt's recall was under class-II…
Sun Pharma in distribution agreement with AstraZeneca for brand Axcer
Sun Pharma will be promoting and distributing Axcer brand in India
AstraZeneca Pharma India Limited (AZPIL) and Sun Pharma have…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations